Caricamento...
The US FDAs withdrawal of the breast cancer indication for Avastin (bevacizumab)
On November 18, 2011, the US Food and Drug Administration (US FDA) announced that breast cancer indication for Avastin (bevacizumab) had been withdrawn after concluding that the drug has not been shown to be safe and effective for the treatment of breast cancer. The specific indication that was with...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3744967/ https://ncbi.nlm.nih.gov/pubmed/23960813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2011.12.001 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|